FILTER

Refine your search with the following facets to narrow down your results.

5 Current news of immunic

image description

Immunic, Inc. Announces Private Placement of up to $240 Million

11-Jan-2024 - Immunic, Inc. announced it has entered into a securities purchase agreement with select accredited investors to purchase shares of common stock (or pre-funded warrants in lieu thereof) in a three-tranche offering. The first tranche is an upfront payment of $80 million at $1.43 per share, which is ...

financing shares

Immunic AG Awarded Research Grant by German Federal Ministry of Education and Research

06-Aug-2019 - Immunic, Inc. announced that the German Federal Ministry of Education and Research has awarded its subsidiary, Immunic AG, a grant in the amount of up to EUR 653,535 (approximately USD 730,000) in support of the InnoMuNiCH (Innovations through Munich-Nippon Cooperation in Healthcare) project. The ...

research grants T-helper cells
image description

Biotech start-up Immunic Therapeutics to trade on NASDAQ

16-Apr-2019 - Immunic’s listing on the NASDAQ has been achieved through a reverse takeover, with the company slipping under the umbrella of listed company Vital Therapies, Inc. in a stock-for-stock transaction. After the closing of the transaction, the company will operate under the name Immunic, Inc., and ...

Immunic acquires two promising drug development programs

29-Sep-2016 - Immunic AG (Immunic), a biotech company in Planegg-Martinsried near Munich, Germany, announced that it acquired 4SC AG’s (4SC) immunology portfolio, which includes two drug development programs and associated intellectual property and know-how. Immunic will continue all research and development ...

autoimmune diseases cytokines drug candidates +4

Immunic successfully closes Series A financing round

28-Sep-2016 - Immunic AG (Immunic), a recently formed private start-up biotech company in Planegg-Martinsried near Munich, Germany, announced that it has closed its Series A financing round totaling EUR 17.5 million of preferred stock financing. The financing round was led by Life Sciences Partners V ...

High-Tech Gründerfonds Management Series A financing